Radiation Therapy Oncology Group
Clinical trials sponsored by Radiation Therapy Oncology Group, explained in plain language.
-
Could breast cancer radiation be cut from 6 weeks to just 3?
Disease control OngoingThis large study tested if a shorter, more intense 3-week radiation course is as effective and safe as the standard 5-6 week course for women with early-stage breast cancer after lumpectomy. It aimed to see if the shorter schedule provides the same cancer control with similar sid…
Phase: PHASE3 • Sponsor: Radiation Therapy Oncology Group • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Major trial tests drug combo to stop Cancer's return after surgery
Disease control OngoingThis large study aimed to see if adding a targeted drug called cetuximab to standard radiation therapy helps patients live longer after surgery for advanced head and neck cancer. It involved 702 patients who had their tumors removed but were at intermediate risk of the cancer com…
Phase: PHASE3 • Sponsor: Radiation Therapy Oncology Group • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Major trial seeks better survival for prostate cancer with expanded radiation
Disease control OngoingThis large study is testing whether adding radiation to the entire pelvic area, along with standard hormone-blocking drugs and prostate radiation, helps men with aggressive prostate cancer live longer. It compares this more extensive treatment to the standard approach of targetin…
Phase: PHASE3 • Sponsor: Radiation Therapy Oncology Group • Aim: Disease control
Last updated Mar 12, 2026 13:50 UTC